Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57

1.

Ruxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.

Jain P, Keating M, Renner S, Cleeland C, Xuelin H, Gonzalez GN, Harris D, Li P, Liu Z, Veletic I, Rozovski U, Jain N, Thompson P, Bose P, DiNardo C, Ferrajoli A, O'Brien S, Burger J, Wierda W, Verstovsek S, Kantarjian H, Estrov Z.

Lancet Haematol. 2017 Feb;4(2):e67-e74. doi: 10.1016/S2352-3026(16)30194-6.

PMID:
28089238
2.

Sleep-wake disturbances after traumatic brain injury.

Ouellet MC, Beaulieu-Bonneau S, Morin CM.

Lancet Neurol. 2015 Jul;14(7):746-57. doi: 10.1016/S1474-4422(15)00068-X. Review.

PMID:
26067127
3.

Losing sleep.

Spiegelhalder K, Riemann D.

Lancet Neurol. 2015 Jun;14(6):571. doi: 10.1016/S1474-4422(15)00065-4. No abstract available.

PMID:
25987277
4.

The neurobiology, investigation, and treatment of chronic insomnia.

Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K.

Lancet Neurol. 2015 May;14(5):547-58. doi: 10.1016/S1474-4422(15)00021-6. Review.

PMID:
25895933
5.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Sax PE, Wohl D, Yin MT, Post F, DeJesus E, Saag M, Pozniak A, Thompson M, Podzamczer D, Molina JM, Oka S, Koenig E, Trottier B, Andrade-Villanueva J, Crofoot G, Custodio JM, Plummer A, Zhong L, Cao H, Martin H, Callebaut C, Cheng AK, Fordyce MW, McCallister S; GS-US-292-0104/0111 Study Team..

Lancet. 2015 Jun 27;385(9987):2606-15. doi: 10.1016/S0140-6736(15)60616-X. Erratum in: Lancet. 2016 Apr 30;387(10030):1816.

PMID:
25890673
6.

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study.

Molina JM, Orkin C, Iser DM, Zamora FX, Nelson M, Stephan C, Massetto B, Gaggar A, Ni L, Svarovskaia E, Brainard D, Subramanian GM, McHutchison JG, Puoti M, Rockstroh JK; PHOTON-2 study team..

Lancet. 2015 Mar 21;385(9973):1098-106. doi: 10.1016/S0140-6736(14)62483-1.

PMID:
25659285
7.

Orexin receptor antagonists: a new treatment for insomnia?

Riemann D, Spiegelhalder K.

Lancet Neurol. 2014 May;13(5):441-3. doi: 10.1016/S1474-4422(13)70311-9. No abstract available.

PMID:
24680373
8.

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial.

Michelson D, Snyder E, Paradis E, Chengan-Liu M, Snavely DB, Hutzelmann J, Walsh JK, Krystal AD, Benca RM, Cohn M, Lines C, Roth T, Herring WJ.

Lancet Neurol. 2014 May;13(5):461-71. doi: 10.1016/S1474-4422(14)70053-5.

PMID:
24680372
9.

Waking up to the merits of mindfulness.

Burki TK.

Lancet Oncol. 2014 Feb;15(2):e57. No abstract available.

PMID:
24627912
10.

States and US Government spar over medical marijuana.

Furlow B.

Lancet Oncol. 2012 May;13(5):450. No abstract available.

PMID:
22701888
11.

Chronic insomnia.

Morin CM, Benca R.

Lancet. 2012 Mar 24;379(9821):1129-41. doi: 10.1016/S0140-6736(11)60750-2. Review. Erratum in: Lancet. 2012 Apr 21;379(9825):1488.

PMID:
22265700
12.

Let there be sleep--on time.

Cardinali DP, Golombek DA.

Lancet. 2009 Feb 7;373(9662):439-41. doi: 10.1016/S0140-6736(08)61813-9. No abstract available.

PMID:
19054553
13.

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

Rajaratnam SM, Polymeropoulos MH, Fisher DM, Roth T, Scott C, Birznieks G, Klerman EB.

Lancet. 2009 Feb 7;373(9662):482-91. doi: 10.1016/S0140-6736(08)61812-7. Erratum in: Lancet. 2009 Apr 11;373(9671):1252.

PMID:
19054552
14.

Updated findings on the effects of stellate-ganglion block on hot flushes and night awakenings.

Lipov EG, Joshi JR, Xie H, Slavin KV.

Lancet Oncol. 2008 Sep;9(9):819-20. doi: 10.1016/S1470-2045(08)70218-3. No abstract available.

PMID:
18760240
15.

Insomnia.

Sullivan E.

Lancet. 2008 May 3;371(9623):1497. doi: 10.1016/S0140-6736(08)60642-X. No abstract available.

PMID:
18456091
16.

Insomnia.

Sateia MJ, Nowell PD.

Lancet. 2004 Nov 27-Dec 3;364(9449):1959-73. Review.

PMID:
15567013
17.

Transmissible spongiform encephalopathies.

Collins SJ, Lawson VA, Masters CL.

Lancet. 2004 Jan 3;363(9402):51-61. Review.

PMID:
14723996
18.

Familial and sporadic fatal insomnia.

Montagna P, Gambetti P, Cortelli P, Lugaresi E.

Lancet Neurol. 2003 Mar;2(3):167-76. Review.

PMID:
12849238
19.

Treatment for insomnia.

Finucane TE.

Lancet. 2002 Apr 20;359(9315):1434; author reply 1434. No abstract available.

PMID:
11978363
20.

Treatment for insomnia.

Schreiber V.

Lancet. 2002 Apr 20;359(9315):1434; author reply 1434. No abstract available.

PMID:
11978362

Supplemental Content

Loading ...
Support Center